Challenges and solutions in the development of genomic biomarker panels: A systematic phased approach

K. Shahzad, A. Fatima, M. Cadeiras, N. Wisniewski, G. Bondar, R. Cheng, E. Reed, M. C. Deng

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

In the post-genome era, high throughput gene expression profiling has been successfully used to develop genomic biomarker panels (GBP) that can be integrated into clinical decision making. The development of GBPs in the context of personalized medicine is a scientifically challenging and resource-intense process. It needs to be accomplished in a systematic phased approach to address biological variation related to a clinical phenotype (e.g. disease etiology, gender, etc.) and minimize technical variation (noise). Here we present the methodological aspects of GBP development based on the experience of the Cardiac Allograft Rejection Gene Expression Observation (CARGO) study, a study that lead to the development of a molecular classifier for rejection screening in heart transplant patients.

Original languageEnglish (US)
Pages (from-to)334-341
Number of pages8
JournalCurrent Genomics
Volume13
Issue number4
DOIs
StatePublished - Jun 1 2012

Keywords

  • Gene expression transplantation
  • Genomics
  • Multiorgan dysfunction
  • Personalized medicine
  • Post-genome era

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Challenges and solutions in the development of genomic biomarker panels: A systematic phased approach'. Together they form a unique fingerprint.

  • Cite this

    Shahzad, K., Fatima, A., Cadeiras, M., Wisniewski, N., Bondar, G., Cheng, R., Reed, E., & Deng, M. C. (2012). Challenges and solutions in the development of genomic biomarker panels: A systematic phased approach. Current Genomics, 13(4), 334-341. https://doi.org/10.2174/138920212800793339